NEW YORK (360Dx) – Siemens Healthineers today said that the US Food and Drug Administration has cleared its high-sensitivity troponin I assays for use on its Atellica IM and Advia Centaur XP/XPT immunoassay analyzers to aid in the early diagnosis of myocardial infarctions, or heart attacks.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.